3rd Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis (MENACTRIMS 2017)

The 3rd Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis (MENACTRIMS 2017) is dedicated to excellence in Multiple Sclerosis education and research.

The 3rd Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis (MENACTRIMS 2017) covers topics such as:

• MS pathology
• Recent advances in MS therapy
• Epidemiology of MS
• Immunology of MS
• Update on Secondary Progressive MS
• MS diagnosis
• Pediatric MS
• Neuromyelitis Optica
• Biomarkers in MS

The 3rd Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis (MENACTRIMS 2017) brings together:

• Neurologists
• Healthcare professionals and researchers involved in MS clinical care or research
• Residents with interest in Neurology
• Clinical Researchers